Intellia Therapeutics, Inc.
NTLA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$519 | -$481 | -$474 | -$268 |
| Dep. & Amort. | $10 | $9 | $8 | $7 |
| Deferred Tax | $0 | $0 | $0 | $9 |
| Stock-Based Comp. | $154 | $134 | $91 | $47 |
| Change in WC | $12 | -$52 | -$54 | -$23 |
| Other Non-Cash | -$6 | -$3 | $96 | $3 |
| Operating Cash Flow | -$349 | -$394 | -$333 | -$225 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$6 | -$14 | -$58 | -$13 |
| Net Acquisitions | $0 | $0 | -$45 | -$3 |
| Inv. Purchases | -$936 | -$904 | -$429 | -$1,021 |
| Inv. Sales/Matur. | $1,067 | $887 | $648 | $486 |
| Other Inv. Act. | $0 | $0 | $45 | $0 |
| Investing Cash Flow | $126 | -$31 | $160 | -$551 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $177 | $120 | $566 | $694 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $9 | $11 | $17 | $43 |
| Financing Cash Flow | $186 | $130 | $583 | $737 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$38 | -$295 | $410 | -$39 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $240 | $535 | $125 | $165 |
| End Cash | $203 | $240 | $535 | $125 |
| Free Cash Flow | -$355 | -$408 | -$392 | -$238 |